Depressive symptoms after child relinquishment remain uncommon in pooled surrogacy data
The mental health question at the center of surrogacy is not abstract. When a surrogate mother gives birth and then relinquishes the child to intended parents, the emotional transition can be immediate, intense, and shaped by family structure, legal context, and the degree of support available before and after delivery. In this systematic review and meta-analysis, the pooled prevalence of depressive symptoms after child relinquishment was low, but the estimate rested on a small and uneven evidence base that leaves substantial uncertainty around the true burden in real-world practice.
Eleven studies including 637 surrogate mothers met the review criteria, and six of those studies contributed to the meta-analysis. The pooled prevalence was 3%, with a 95% confidence interval ranging from 0% to 16%. That spread matters. A point estimate near zero may sound reassuring, but a confidence interval that stretches into the mid-teens signals fragility in the underlying data and leaves room for clinically meaningful depression in some settings.
Why the pooled estimate stays low while the uncertainty stays wide
A surrogate pregnancy is not biologically identical to an ordinary postpartum experience, yet it shares many of the same neuroendocrine and psychosocial stressors that shape mood after delivery. Sleep disruption, hormonal shifts, physical recovery, and the sudden reorganization of maternal identity can all influence affective symptoms. In surrogacy, those pressures are layered on top of the relinquishment process itself, which can be emotionally benign for some women and destabilizing for others. The limited literature suggests that the average prevalence of depressive symptoms is low, but averages can hide very different emotional trajectories across countries, legal systems, and payment structures.
The review’s subgroup findings point in that direction. Studies conducted in India showed a higher prevalence of 27.3%, while studies from the UK and USA reported 0%. Those differences should not be read as a simple geographic ranking of risk. They likely reflect differences in recruitment, social supports, stigma, compensation arrangements, legal protections, and how depressive symptoms were measured across studies. A pooled depression estimate that appears low in one jurisdiction may have little relevance in a setting where surrogacy is highly commercialized or socially marginalized.
The India signal raises more questions than it answers
The contrast between the India subgroup and the UK or USA studies is the most clinically provocative result in the paper. It suggests that context may matter as much as the biological event of childbirth itself. Surrogacy can be embedded in very different social frameworks: in some settings, the surrogate may have stronger counseling access and clearer postdelivery planning; in others, financial pressure and limited mental health resources may amplify vulnerability. Depression after relinquishment is therefore unlikely to be driven by a single mechanism. It emerges from the interaction of obstetric recovery, maternal attachment dynamics, social expectations, and the local ethics of third-party reproduction.
Risk-of-bias stratification also shifted the estimates in an unexpected direction. Studies judged to have a low risk of bias reported a 9% prevalence, whereas those with moderate risk of bias reported 0%. In practice, that pattern often means the better studies were more likely to capture symptoms that weaker designs missed. It also suggests that the apparently reassuring overall estimate may be partly influenced by measurement limitations rather than a uniformly low symptom burden.
A small evidence base limits certainty more than the point estimate does
This review searched PubMed, Web of Science, Scopus, and Embase for studies published between 1 January 1990 and 31 December 2025, then screened reference lists of eligible papers. The broad search strategy strengthens confidence that the topic was approached systematically. Still, only 11 studies were identified, and just six were suitable for meta-analysis. That is a thin base on which to build global reassurance about psychological outcomes after surrogacy.
The inclusion criterion of depressive symptoms within 1 year postpartum is clinically sensible, but it also means the analysis captures a wide window during which symptom timing may vary substantially. Early postpartum depression can present differently from symptoms that emerge months later, after legal transfers are complete and family routines have settled. Without consistent follow-up time points, the pooled prevalence blends together potentially distinct phases of recovery and adjustment.
No significant publication bias was detected, which is helpful but not definitive. With so few studies, conventional tests for publication bias have limited power. Small negative studies can still go missing, and studies from more visible health systems may be overrepresented relative to settings where surrogacy is less formally documented.
Mental health support should follow the patient, not the assumption
The bedside implication is straightforward: a low pooled prevalence should not be mistaken for a low-priority issue. Even a small proportion of affected surrogate mothers represents women who may need screening, counseling, and follow-up during a period that already carries obstetric and social stress. Postpartum mental health pathways should not assume that relinquishment automatically protects against depression, nor should they assume that all surrogates are equally resilient.
Support may be especially important in resource-limited settings, where continuity of care is weaker and psychological services are harder to access. The review’s own framing points in that direction, and the subgroup data make the case more concrete. If depressive symptoms are more common in certain environments, then universal reassurance would be the wrong clinical response. Screening needs to be tied to context, with attention to legal arrangements, social support, and the surrogate’s own expectations before delivery.
The literature still cannot define who is most vulnerable
What remains unresolved is the pattern of risk within the surrogate population itself. The included studies do not provide enough detail here to identify reliable predictors such as parity, age, prior mental health history, relationship to the intended parents, payment model, or the degree of planned postpartum contact. Without those details, the field cannot move from estimating prevalence to preventing symptoms in the women most likely to develop them.
For now, the best reading of the evidence is restrained. Depressive symptoms after child relinquishment appear uncommon in the pooled analysis, but the estimate is based on few studies, broad confidence limits, and striking cross-setting differences. The study offers a useful first map, not a settled answer, and future work will need better follow-up, more consistent symptom measurement, and richer reporting of the social conditions surrounding surrogacy.